Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
CEN Case Reports
Published in: CEN Case Reports 2/2017

01-11-2017 | Letter to the editor

Acute demyelinating neuropathy associated with rituximab treatment in a patient with relapsing nephrotic syndrome

Authors: Giuliana Galassi, Francesca Testa, Francesca Bianchi, Gianni Cappelli, Annalisa Chiari

Published in: CEN Case Reports | Issue 2/2017

Login to get access

Excerpt

To the Editor, …
Literature
1.
Cravedi P. Rituximab in membranous nephropathy: not all studies are created equal. Nephron. 2017;135:46–50.CrossRef
2.
Iancu Ferfoglia R, Guimarães-Costa R, Viala K, et al. Long-term efficacy of rituximab in IgM anti-myelin-associated glycoprotein neuropathy: RIMAG follow-up study. J Peripher Nerv Syst. 2016;21:10–4.CrossRef
3.
Stork AC, Notermans NC, Vrancken AF, Cornblath DR, van der Pol WL. Rapid worsening of IgM anti-MAG demyelinating polyneuropathy during rituximab treatment. J Peripher Nerv Syst. 2013;18:189–91.CrossRef
4.
Terenghi F, Ardolino G, Nobile-Orazio E. Guillain–Barré syndrome after combined CHOP and rituximab therapy in non-Hodgkin lymphoma. J Peripher Nerv Syst. 2007;12:142–3.CrossRef
5.
Weiss MD, Becker P. Paradoxical worsening of anti-myelin associated glycoprotein polyneuropathy following rituximab. Muscle Nerve. 2014;49:457–8.CrossRef
Metadata
Title
Acute demyelinating neuropathy associated with rituximab treatment in a patient with relapsing nephrotic syndrome
Authors
Giuliana Galassi
Francesca Testa
Francesca Bianchi
Gianni Cappelli
Annalisa Chiari
Publication date
01-11-2017
Publisher
Springer Singapore
Published in
CEN Case Reports / Issue 2/2017
Electronic ISSN: 2192-4449
DOI
https://doi.org/10.1007/s13730-017-0264-3

Other articles of this Issue 2/2017

CEN Case Reports 2/2017 Go to the issue

Case report

A case of acetaminophen-induced acute tubulointerstitial nephritis in adult

Case report

Cavernous sinus thrombosis in a patient with nephrotic syndrome

Case report

Inherited, not acquired, Gitelman syndrome in a patient with Sjögren’s syndrome: importance of genetic testing to distinguish the two forms

Case report

A case of renal dysfunction caused by pelvic organ prolapse

Case report

A case of perirenal extramedullary hematopoiesis in a patient with primary myelofibrosis

Case report

Diffuse large B-cell lymphoma presenting as bilateral renal infiltration leading to acute kidney injury
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits